Research and Markets
Target Product Profiles 2009: Physician Insights on Key Attributes: Hepatitis C Virus
Published in Hepatitis Weekly, March 29th, 2010
Hepatitis C Virus: A therapy that is a protease inhibitor that when used in combination with peg-IFN/ribavirin, achieves significantly higher SVR in genotype 1 patients with only 24 weeks of treatment compared with the standard 48 week therapy with peg-IFN/ribavirin.
Using Target Product Profiles in Your Market Strategy
Keywords: Automotive, Biotechnology, Clinical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2010-03-29)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
New hepatitis C virus study results from D.K. Moonka et al described - Hepatitis C Virus
Research from University of Ottawa in the area of hepatitis C virus published - Hepatitis C Virus
Research on hepatitis C virus discussed by scientists at University of Washington, Medical Department - Hepatitis C Virus
Study findings on hepatitis C virus are outlined in reports from Federal University - Kidney Disease
Reports summarize kidney disease study results from J.Y. Kim and co-researchers - Enzyme Research
Reports from Pennsylvania State University advance knowledge in enzyme research - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
